These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12392744)

  • 1. Modification of the pyridine moiety of non-peptidyl indole GnRH receptor antagonists.
    Simeone JP; Bugianesi RL; Ponpipom MM; Yang YT; Lo JL; Yudkovitz JB; Cui J; Mount GR; Ren RN; Creighton M; Mao AH; Vincent SH; Cheng K; Goulet MT
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3329-32. PubMed ID: 12392744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally bioavailable, indole-based nonpeptide GnRH receptor antagonists with high potency and functional activity.
    Ashton WT; Sisco RM; Kieczykowski GR; Yang YT; Yudkovitz JB; Cui J; Mount GR; Ren RN; Wu TJ; Shen X; Lyons KA; Mao AH; Carlin JR; Karanam BV; Vincent SH; Cheng K; Goulet MT
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2597-602. PubMed ID: 11551758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent nonpeptide GnRH receptor antagonists derived from substituted indole-5-carboxamides and -acetamides bearing a pyridine side-chain terminus.
    Ashton WT; Sisco RM; Yang YT; Lo JL; Yudkovitz JB; Gibbons PH; Mount GR; Ren RN; Butler BS; Cheng K; Goulet MT
    Bioorg Med Chem Lett; 2001 Jul; 11(13):1727-31. PubMed ID: 11425547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.
    Rowley M; Hallett DJ; Goodacre S; Moyes C; Crawforth J; Sparey TJ; Patel S; Marwood R; Patel S; Thomas S; Hitzel L; O'Connor D; Szeto N; Castro JL; Hutson PH; MacLeod AM
    J Med Chem; 2001 May; 44(10):1603-14. PubMed ID: 11334570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors.
    Fraley ME; Arrington KL; Hambaugh SR; Hoffman WF; Cunningham AM; Young MB; Hungate RW; Tebben AJ; Rutledge RZ; Kendall RL; Huckle WR; McFall RC; Coll KE; Thomas KA
    Bioorg Med Chem Lett; 2003 Sep; 13(18):2973-6. PubMed ID: 12941314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAR studies of novel 5-substituted 2-arylindoles as nonpeptidyl GnRH receptor antagonists.
    Chu L; Lo JL; Yang YT; Cheng K; Smith RG; Fisher MH; Wyvratt MJ; Goulet MT
    Bioorg Med Chem Lett; 2001 Feb; 11(4):515-7. PubMed ID: 11229760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted indole-5-carboxamides and -acetamides as potent nonpeptide GnRH receptor antagonists.
    Ashton WT; Sisco RM; Yang YT; Lo JL; Yudkovitz JB; Cheng K; Goulet MT
    Bioorg Med Chem Lett; 2001 Jul; 11(13):1723-6. PubMed ID: 11425546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial structure-activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles.
    Chu L; Hutchins JE; Weber AE; Lo JL; Yang YT; Cheng K; Smith RG; Fisher MH; Wyvratt MJ; Goulet MT
    Bioorg Med Chem Lett; 2001 Feb; 11(4):509-13. PubMed ID: 11229759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptor.
    Vera MD; Lundquist JT; Chengalvala MV; Cottom JE; Feingold IB; Garrick LM; Green DM; Hauze DB; Mann CW; Mehlmann JF; Rogers JF; Shanno L; Wrobel JE; Pelletier JC
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2512-5. PubMed ID: 20236823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles.
    Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
    J Med Chem; 1993 Dec; 36(26):4230-8. PubMed ID: 8277505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Aryl indole NK(1) antagonists: optimisation of the amide substituent.
    Shaw D; Chicchi GG; Elliott JM; Kurtz M; Morrison D; Ridgill MP; Szeto N; Watt AP; Williams AR; Swain CJ
    Bioorg Med Chem Lett; 2001 Dec; 11(23):3031-4. PubMed ID: 11714604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 2-(4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-3-yl)-ethylamine derivatives as novel GnRH receptor antagonists.
    Chen M; Guo Z; Lanier MC; Zhao L; Betz SF; Huang CQ; Loweth CJ; Ashweek NJ; Liu XJ; Struthers RS; Bradbury MJ; Behan JW; Wen J; O'Brien Z; Saunders J; Zhu YF
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3845-50. PubMed ID: 17521908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists.
    Imada T; Cho N; Imaeda T; Hayase Y; Sasaki S; Kasai S; Harada M; Matsumoto H; Endo S; Suzuki N; Furuya S
    J Med Chem; 2006 Jun; 49(13):3809-25. PubMed ID: 16789738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists.
    Crawforth J; Goodacre S; Maxey R; Bourrain S; Patel S; Marwood R; O'Connor D; Herbert R; Hutson P; Rowley M
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2701-3. PubMed ID: 11133072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of an Orally Bioavailable Gonadotropin-Releasing Hormone Receptor Antagonist.
    Kim SM; Lee M; Lee SY; Park E; Lee SM; Kim EJ; Han MY; Yoo T; Ann J; Yoon S; Lee J; Lee J
    J Med Chem; 2016 Oct; 59(19):9150-9172. PubMed ID: 27608177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of highly potent CGRP receptor antagonists.
    Stump CA; Bell IM; Bednar RA; Bruno JG; Fay JF; Gallicchio SN; Johnston VK; Moore EL; Mosser SD; Quigley AG; Salvatore CA; Theberge CR; Blair Zartman C; Zhang XF; Kane SA; Graham SL; Vacca JP; Williams TM
    Bioorg Med Chem Lett; 2009 Jan; 19(1):214-7. PubMed ID: 19010673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New tetrahydrobenzindoles as potent and selective 5-HT(7) antagonists with increased In vitro metabolic stability.
    Kikuchi C; Suzuki H; Hiranuma T; Koyama M
    Bioorg Med Chem Lett; 2003 Jan; 13(1):61-4. PubMed ID: 12467617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potent and selective oxytocin antagonists. Part 1: indole and benzofuran derivatives.
    Wyatt PG; Allen MJ; Chilcott J; Foster A; Livermore DG; Mordaunt JE; Scicinski J; Woollard PM
    Bioorg Med Chem Lett; 2002 May; 12(10):1399-404. PubMed ID: 11992786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R).
    Pelletier JC; Chengalvala MV; Cottom JE; Feingold IB; Green DM; Hauze DB; Huselton CA; Jetter JW; Kopf GS; Lundquist JT; Magolda RL; Mann CW; Mehlmann JF; Rogers JF; Shanno LK; Adams WR; Tio CO; Wrobel JE
    J Med Chem; 2009 Apr; 52(7):2148-52. PubMed ID: 19271735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationship of 1H-indole-3-carboxylic acid pyridine-3-ylamides: a novel series of 5-HT2C receptor antagonists.
    Park CM; Kim SY; Park WK; Park NS; Seong CM
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3844-7. PubMed ID: 18602261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.